|  | “The Trends Behind Successful Cancer Treatments” Powerful new cancer treatments such as CAR T-cell therapy, anti-cancer vaccines and immunotherapies are showing unprecedented response rates and bringing patients new hope. The uptick of successes are generating optimism among scientists and companies looking to get their drug to market. Is your approach setting you up for success? Unlock More Potential with TD2. |
Today's Rundown Featured Story | | | Wednesday, January 8, 2020 As Bristol-Myers Squibb looked to subsume Big Biotech Celgene, its chief scientific officer Thomas Lynch decided to walk. |
|
|---|
|
 | Thank you to Rho for sponsoring this year's JPM 2020 coverage. |
Top Stories Wednesday, January 8, 2020 A year after Immunic Therapeutics secured the right to license an inflammatory bowel disease program from Daiichi Sankyo, the German biotech is pulling the trigger on that option and preparing to bring it into phase 1. Wednesday, January 8, 2020 NorthSea Therapeutics has raised a $40 million (€36 million) series B round to wrap up its phase 2b nonalcoholic steatohepatitis (NASH) trial. The financing comes months after NorthSea enrolled the first NASH patient in the trial of its structurally engineered fatty acid icosabutate. Wednesday, January 8, 2020 Nference has raised $60 million. The Mayo Clinic-backed series B round positions nference to forge ahead with its effort to capture and analyze health data, including unstructured information, to help researchers discover and develop medicines. Wednesday, January 8, 2020 General Atlantic poured $50 million into Adagene’s $69 million series D, joining the likes of Eight Roads Ventures China, F-Prime Capital, WuXi Corporate Venture Fund and Sequoia China. The latest round will push the company’s lead immunotherapies through the clinic as well as support further development of its drug discovery technology. Wednesday, January 8, 2020 Verastem Oncology has signed a pact to license a drug targeting KRAS-mutation positive cancers from Chugai. Tuesday, January 7, 2020 Gastric weight-loss balloon manufacturer Allurion Technologies has raised $34 million in new funding to boost its commercialization efforts and entry into the U.S. market, pending FDA approval. |  | Experts in our field; with 20+ years’ experience in Viral Vector & plasmid DNA (R&D, High Quality and GMP) manufacture for pre-clinical, clinical & commercial supply. Take a virtual tour of our facilities & find out more about our expansion project. |
Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|---|
|
Resources Sponsored by: ICON Clinical Research Ltd The beginning of this digital transformation is well underway and is likely to accelerate. Read our white paper, “Digital Disruption in Biopharma: How Digital Transformation can reverse declining ROI on R&D,” to learn more. Sponsored by: snapIoT, Inc. Download this white paper and read the expert feedback that snapIoT has gathered from industry thought leaders on the evolution, evaluation, and use of telemedicine solutions in clinical trials. Sponsored by: EVERSANA How are your launch strategies can convert “innovation” into value for patients? Sponsored by: Eli Lilly and Company in partnership with Xcenda Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system. Sponsored by: Amazon Web Services From IoT to data management to high-performance computing and machine learning, leading life sciences organizations are using Amazon Web Services (AWS) to develop scalable, global, predictable, and secure solutions to modernize clinical trials while mitigating risks Sponsored by: Outer Edge Technology, LLC Why companies leverage the expertize of industry focused cloud service providers to design and build quality systems and facilitate the FDA Validation of Mission Critical Apps in the Cloud. Sponsored by: Colorcon Learn more: Best practices for defending supply chain security and compliance by efficiently managing product authentication. Sponsored by: Metabolon Small or emerging pharmaceutical and biotech companies pursuing novel molecules and targets have two important goals: achieve clinical success and attract new rounds of funding. While there’s never a guarantee of either, certain actions can influence the outcome in your favor. Sponsored by: Catalent Learn how recent innovations in demand-led supply and direct-to-patient distribution are converging to create a next-generation clinical supply chain that is flexible, lean and most importantly patient-centric. Sponsored by: Altran This whitepaper highlights the challenges of implementing the right digital twin strategy while providing key use cases in the manufacturing domain for which a digital twin is extremely useful and several examples of technology trends that will shape the future. Sponsored by: Catalent Pharma Solutions In this Q&A, four Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the success of a biologic when embarking upon the commercial manufacturing journey. | 
